- Quantifying the duration of the preclinical detectable phase in cancer screening: a systematic review
-
Geurts SME, Aarts AMWM, Verbeek ALM, Chen THH, Broeders MJM, Duffy SW
- KMID: 2529772
- Epidemiol Health.
- 2022;44(1):e2022008.
- doi: 10.4178/epih.e2022008
OBJECTIVES: The aim of this study was to provide an overview of published mathematical estimation approaches to quantify the duration of the preclinical detectable phase (PCDP) using data from cancer... -
- CITED
-
- Close
- SHARE
-
- Close
